This invention relates to compositions comprising thalidomide and irinotecan which can be used in the treatment or prevention of colorectal cancer. The invention also relates to methods of treating or preventing colorectal cancer which comprise the administration of thalidomide and irinotecan to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of irinotecan which comprise th...

This invention relates to compositions comprising thalidomide and another anticancer drug which can be used in the treatment or prevention of cancer. Preferred anticancer drugs are topoisomerase inhibitors. A particular composition comprises thalidomide or a pharmaceutically acceptable salt solvate or clathrate thereof and irinotecan. The invention also relates to methods of treating or preventing cancer which comprise the administration of a thalidomide and another anticancer drug to a patient ...

Una cantidad terapéuticamente eficaz de irinotecán o una sal un solvato un hidrato o un clatrato farmacéuticamente aceptable del mismo y una cantidad terapéuticamente eficaz de talidomida o una sal un solvato un hidrato o un clatrato farmacéuticamente aceptable de la misma para tratar cáncer de colon o cáncer rectal.

This invention relates to compositions comprising thalidomide and another anti-cancer drug which can be used in the treatment or prevention of cancer. Preferred anti-cancer drugs are topoisomerase inhibitors. A particular composition comprises thalidomide or a pharmaceutically acceptable salt solvate or clathrate thereof and irinotecan. The invention also relates to methods of treating or preventing cancer which comprise the administration of a thalidomide and another anti-cancer drug to a patie...

This invention relates to compositions comprising thalidomide and another anti-cancer drug which can be used in the treatment or prevention of cancer. Preferred anti-cancer drugs are topoisomerase inhibitors. A particular composition comprises thalidomide or a pharmaceutically acceptable salt solvate or clathrate thereof and irinotecan. The invention also relates to methods of treating or preventing cancer which comprise the administration of a thalidomide and another anti-cancer drug to a patie...

This invention relates to compositions comprising thalidomide and irinotecan which can be used in the treatment or prevention of colorectal cancer. The invention also relates to methods of treating or preventing colorectal cancer which comprise the administration of thalidomide and irinotecan to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of irinotecan which comprise th...

This invention relates to compositions comprising thalidomide and another anti-cancer drug which can be used in the treatment or prevention of cancer. Preferred anti-cancer drugs are topoisomerase inhibitors. A particular composition comprises thalidomide or a pharmaceutically acceptable salt solvate or clathrate thereof and irinotecan. The invention also relates to methods of treating or preventing cancer which comprise the administration of a thalidomide and another anti-cancer drug to a patie...

This invention relates to compositions comprising thalidomide and another anti-cancer drug which can be used in the treatment or prevention of cancer. Preferred anti-cancer drugs are topoisomerase inhibitors. A particular composition comprises thalidomide or a pharmaceutically acceptable salt solvate or clathrate thereof and irinotecan. The invention also relates to methods of treating or preventing cancer which comprise the administration of a thalidomide and another anti-cancer drug to a patie...